Lilly LEAP Project Update & Site Tour
We have reached capacity for both the education session and tour spots. If you would like to place your name on the waitlist please reach out to Anna Gleason at anna@indianaconstruction.org and note if you would like to be on the waitlist for just the education session or both.
Join the Indiana Construction Roundtable on Friday, June 12th for a unique, on-site learning experience at one of the largest and most significant construction projects currently underway in Indiana—the Eli Lilly & Company LEAP (Limitless Exploration/Advanced Pace) project in Lebanon.
This ICR June education event will feature a project update and educational briefing from Lilly, followed by an optional guided tour of the LEAP project site (limited to the first 50 people who register). Attendees will gain firsthand insight into the scale, complexity, and coordination required for a transformative megaproject of this magnitude, as well as its impact on Indiana’s economy and construction industry.
In 2022, Lilly announced plans to invest in two new manufacturing sites at the LEAP District. In 2024, Lilly announced it would manufacture its obesity and weight-loss drugs Mounjaro and Zepbound at Lilly Lebanon API which is anticipated to open in 2027. On May 6, 2026, Lilly announced an additional $4.5 billion investment in the LEAP district making their total investment to date approximately $18 billion. This will be a first-hand way to learn about Indiana’s largest current capital project.
Speakers include:
- Mike DiGiovanni – Project Director for Support Facilities, Eli Lilly
- Dave Stadolnik – Project Director for Construction, Eli Lilly
Schedule
- 8:00am – Registration/Networking
- 8:30am-9:30am – Formal Program
- 9:30am-10:30am – Site Tour
Event Format & Registration Details
All attendees must register for the education portion, which will include the project update and discussion.
Education Session Location:
Witham Hospital Community Room
2705 N. Lebanon St
North Pavilion – “B” Entrance
Lebanon, IN 46052
During registration, attendees will have the option to sign up for the project site tour by checking an additional box and submitting attendee names in advance. This box must be checked to reserve a tour spot.
IMPORTANT NOTICE
Attendance limits apply:
- Education session: capped at 75 attendees (We have reached capacity)
- Project site tour: capped at 50 attendees (We have reached capacity)
Because advance security clearance is required, attendee names must be provided at registration, and registration will close promptly end of day on Monday, June 8. No late registrations, name additions, or substitutions will be accepted after this deadline.
Following the education session, registered tour participants will be bussed to the LEAP project site for a guided, on-site experience and closer look at active construction operations. Additional tour logistics will be shared with registered attendees closer to the event date.
Registration is closed, as we have reached capacity for this event.
About our Speakers
Mike DiGiovanni, Eli Lilly
Mike DiGiovanni serves as Project Director, overseeing the construction and startup of the Support Facilities at Lilly’s Lebanon API site. In this role, he leads a team of project managers in collaboration with five construction management firms to deliver key site infrastructure, including a welcome center, fire station, large-scale warehouse, and a complex laboratory and administrative facility.
Mike has been with Lilly for more than 24 years and has held a range of leadership and technical roles across plant engineering, drug manufacturing operations, device assembly and manufacturing, and Global Facilities Delivery (GFD). In his prior role within GFD, he led the completion of the RTP Parenteral and Device Manufacturing Facility and subsequently directed an expansion that increased the facility’s capacity by 50 percent.
Prior to joining Lilly, Mike spent five years with Bayer Corporation in its Central Engineering Department, where he served as both a Mechanical Engineer and Project Engineer. During this time, he contributed to the design and construction of facilities supporting healthcare, petrochemical, and agricultural chemical operations.
Mike holds a Bachelor of Science degree in Mechanical Engineering, with a minor in Bioengineering, from the University of Pittsburgh.
Dave Stadolnik, Eli Lilly
Dave Stadolnik is the Project Director overseeing the construction and startup of a variety of buildings at Lilly’s Lebanon API Site. Dave and his team are developing the 606 acres in the Leap District, building the campus central utility plant, tank farm, and providing miles of distributed piping throughout the site. Also, in his responsibility includes two new manufacturing buildings to support our recently approved product Foundayo™.
Dave joined Lilly in the Spring of 2025, has been in the Life Sciences industry for over 33 years in roles including Engineering, Operations, Mergers & Acquisitions, and Quality. He has contributed to global construction projects in Europe, Singapore, and Puerto Rico.
Dave holds a bachelor’s degree in mechanical engineering from Georgia Institute of Technology.
He and his family look forward to relocating to the Indianapolis area in the next few months.